Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

NCT05592756 | Completed

• 1 other identifier: ASCLIN 003/2019
• Study Type: observational
• Target: 2,964
• Locations: 1 country
• Sites: 1

Brief Summary

This study will be an epidemiological inquiry, in communicating confirmed measles cases. The contacts of the index cases will be asked about the measles diagnosis and previous measles vaccination, and will have their vaccination cards checked. They will also be asked about blocking vaccination (opportune or not opportune) and about the development or not of symptoms. Thus, the investigators will have a group of people exposed to infection with a history of vaccination for measles prior to the outbreak versus a group of people exposed without previous vaccination. The frequency of measles cases will be compared in those two groups, allowing to analyze the effectiveness of the vaccine for individual protection. The effectiveness of the vaccine in preventing the spread of the disease will be analyzed, comparing the relative risk of the vaccine history of contact, in the subgroups of index cases with and without previous measles vaccination. The proposed study will involve the collection and analysis of contact data from measles cases oriented to compare vaccinated and unvaccinated, differing from health surveillance actions. This is based on an exhaustive search for contacts of measles cases, preferably aimed at detecting susceptible individuals, with the purpose of implementing blocking vaccination and interrupting the transmission chain. The proposed study seeks a representation of contacts, without the intention of being exhaustive in the search and detection, but prioritizing selection without bias for one of the exposure groups (vaccination). The results may provide technical and scientific support for future decisions by the Ministry of Health regarding the primary immunization schedule, the priority of the age group in vaccination campaigns, the identification of susceptible individuals, and the assessment of the need for a 3rd dose of the vaccine, for measles.

Conditions

Measles

Keywords

soroprotegido

Outcome Measures

Primary Outcomes (1)

• Measles case after index case

  Measles case after index case, confirmed by laboratory or epidemiological link

  18 days after the index case

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Communicants referring to index cases will be interviewed. Approximately 846 contacts, with 5% of losses this amount will be 890 contacts (445 vaccinated and 445 not vaccinated). Assuming an average of 20 contacts per index case, we will need approximately 45 index cases.

You may qualify if:

• Characterize contact with confirmed case of measles at home, waiting room, work, etc.
• Both sexes.
• Willingness to answer the study questionnaire.
• Have had contact with the index case, 6 days before the appearance of the rash, up to 18 days after.
• Have proof of vaccination (or authorize access to health unit vaccination records) or if you no longer have a vaccination card, state whether you have had a vaccine in the past or not.
• Willingness to provide name, address, telephone and other information so that the principal investigator and his team can contact you, if necessary (example: in case of missed visit).
• Willingness to strictly follow the study protocol.
• At least one of the legal guardians for the research participants must be able to understand and sign the Free and Informed Consent Form. If those responsible are unable to sign (illiterate), the IC can be signed by an impartial witness who has accompanied the entire procedure
• For those over 6 years old, and under 18 years old, ability to understand and sign the Informed Consent Form.
• For those over 18, ability to understand and sign the Informed Consent Form.

You may not qualify if:

• Contact with the index case outside the contagion period, that is, after 18 days.
• Inform that you do not know the vaccination status.

Sponsors & Collaborators

• The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz): lead

Study Sites (1)

Eliane Matos dos Santos

Rio de Janeiro, ematos@bio.fiocruz.br, Brazil

Location

MeSH Terms

Conditions

Measles

Condition Hierarchy (Ancestors)

Morbillivirus Infections; Paramyxoviridae Infections; Mononegavirales Infections; RNA Virus Infections; Virus Diseases; Infections

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 20, 2022
• First Posted: October 25, 2022
• Study Start: April 6, 2020
• Primary Completion: August 31, 2021
• Study Completion: March 31, 2022
• Last Updated: June 13, 2023

Record last verified: 2023-06

Locations

BR (1)